Older Adults with Mild Cognitive Impairment Can Reliably Express Their Preferences for Health Care Using Discrete Choice Experiments

Published Jul 3, 2014
Adelaide, South Australia – Researchers from Flinders University found that mild cognitive impairment did not affect the ability of older adults to reliably respond to questions about their preferred rehabilitation services following hip fracture. Older adults (aged 65 years and over) represent an increasing proportion of the population with rising expectations for quality health and aged care services targeted to meet their needs and preferences. A recent study, “Cognitive Overload? An Exploration of the Potential Impact of Cognitive Functioning in Discrete Choice Experiments with Older People in Health Care,” published in Value in Health, was among the first to use discrete choice experiments (DCE), a popular method for quantifying preferences, to focus on older people, especially those with cognitive impairment. Through the use of a questionnaire completed by 74 older adults in the acute phase following a hip fracture to determine whether cognition influenced their ability to reliably complete a DCE, the researchers found that in comparison with those with good cognitive functioning, mild cognitive impairment did not influence the ability of older adults to respond reliably. Study co-author Professor Julie Ratcliffe, PhD, from Flinders University says, “This study demonstrates the ability of older adults, including those with mild cognitive impairment, to make reliable choices in relation to the characteristics of care of importance to them, and demonstrates the potential for the wider utilization of DCE methods to elicit treatment and service preferences across health and aged care sectors.”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

Jun 17, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force” was published in the June 2024 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×